Ceroid storage disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by one other user not shown) | |||
| Line 8: | Line 8: | ||
==Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
* Liver [[cirrhosis]] | |||
* Childhood death | * Childhood death | ||
==Diagnosis== | ==Diagnosis== | ||
| Line 16: | Line 16: | ||
* [[Liver failure]] | * [[Liver failure]] | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
===Biopsy Findings=== | |||
* Ceroid deposits in the [[liver]] | * Ceroid deposits in the [[liver]] | ||
* Ceroid deposits in the [[spleen]] | * Ceroid deposits in the [[spleen]] | ||
Latest revision as of 16:20, 30 July 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
A rare metabolic storage disease characterized by abnormal deposits of a waxy substance called ceroid lipofuscin in various parts of the body such as the liver, spleen and intestinal lining.[1]
Natural History, Complications and Prognosis
- Liver cirrhosis
- Childhood death
Diagnosis
Symptoms
Laboratory Findings
Biopsy Findings
- Ceroid deposits in the liver
- Ceroid deposits in the spleen
- Ceroid deposits in the intestinal lining